article thumbnail

Why Trusted Research Environments are key to the future of genomics  

Drug Discovery World

Genomics is driving a revolution in drug development and, in the long run, the state of public healthcare. The first draft human genome took a decade to create, and 13 years to complete. Advances in sequencing are leading to scientific breakthroughs in preventative care, faster diagnoses, and proactive medical interventions.

Genome 52
article thumbnail

2024 predictions: Experts comment on AI, ML and automation

Drug Discovery World

We’re already seeing biotechs making breakthroughs with AI in this area, with more than 150 small molecule drugs discovered and 15 already in clinical trials. Kishen Chahwala, PhD, Business Development Manager, Enhanc3D Genomics “AI is transforming the way we fight cancer by unlocking the secrets of large and complex datasets.

Genome 139
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why a Platform Approach is Vital for Clinical Research Management Transformation

Cloudbyz

Let’s delve into why this method is paramount for the transformation of clinical research management. Unified Data Management Clinical trials generate vast amounts of data, from patient records to lab results and monitoring findings. Flexibility and Customization Not all clinical trials are the same.

article thumbnail

From data to cure: The journey of AI in cancer trials

Drug Discovery World

Deepika Khedekar , Associate Centralized Clinical Trial Lead at IQVIA Inc, looks at the challenges of utilising artificial intelligence (AI) in oncology clinical research. MIT research 4 tells us a hard truth: about 95% of these trials fall short, leaving behind a trail of broken hopes for cancer patients each year.

Trials 59
article thumbnail

How Potential Changes to the NIH Guidelines Could Impact IBC Review

WCG Clinical

This change expanded the definition of HGT research to include research using nucleic acids that are able to replicate, be transcribed, translated into protein, and/or integrate into the host genome. If implemented, these changes would broaden the definition of HGT to include new gene editing and genome-modified products.

Genome 52
article thumbnail

Recognizing the Real People Behind the Big Data and Artificial Intelligence in Clinical Research

ACRP blog

At the same time, thought leaders in the field are endeavoring to ensure that real people—the ultimate beneficiaries of these rapidly evolving capabilities for clinical trial design and management—are not getting lost in the shuffle. Undoubtedly, the expectations for precision medicine are high,” Olsen adds.

article thumbnail

Can your LNP manufacturing platform cope with the pace of the mRNA revolution?

Pharmaceutical Technology

Genomic medicine development was ranked as the top industry trend for 2023 in a survey of 198 GlobalData Pharma clients and prospects conducted between October and November 2022. Excluding vaccines, there are five mRNA therapeutic products in clinical trial development as of November 2022. billion by 2028.